{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:18:11Z","timestamp":1789564691047,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Egyptian Russian University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Acetaminophen, also known as paracetamol (APAP), is a highly utilized pharmaceutical agent on a global scale, particularly in the field of pediatrics. Regrettably, an overdose of APAP, resulting from the predominant oxidation, has the potential to trigger acute liver injury. The study\u2019s goal was to find an easy, accurate, and selective way to measure APAP, <jats:italic>N<\/jats:italic>-acetyl para benzoquinone imine (NAPQI) (an APAP metabolite that is harmful), and <jats:italic>N<\/jats:italic>-acetyl-<jats:sc>l<\/jats:sc>-cysteine (NAC) (an antidote). Two different chromatographic methods were used. The HPTLC method, which used silica gel 60 F<jats:sub>254<\/jats:sub> as a stationary phase and a developing liquid made up of methanol, ethyl acetate, and glacial acetic acid (8:2:0.2, v\/v\/v) and a UV detection at 254 nm. The HPLC method was developed using a mobile phase consisting of water, methanol, and formic acid in a proportion of (70:30:0.15, v\/v\/v). The stationary phase used in the approach was a C<jats:sub>18<\/jats:sub> column. Analytes quantification was established utilizing a UV detector operating at a wavelength of 254 nm. The present methods make it possible to measure the amount of APAP in plasma samples. When it comes to pharmacokinetics or medication levels in children\u2019s plasma, for example, this may be also very helpful. The current methods can quantify NAPQI, which is helpful in figuring out drug concentrations in individuals with APAP intoxication diagnoses. Additionally, the current approaches can estimate NAC as an antidote; as a result, this study is a complete study because it can analyse drug, toxic metabolite, and antidote in one analytical run. Using the innovative blue applicability grade index software, which measures the practicality of procedures, both methodologies were compared with a reported methods. Additionally, the achievement of the eco-friendliness profile of the designed procedures was assessed. Both techniques passed the ICH validation tests.<\/jats:p>","DOI":"10.1038\/s41598-025-86070-3","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T16:57:01Z","timestamp":1738601821000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Two chromatographic methods for analyzing paracetamol in spiked human plasma with its toxic metabolite, N-acetyl parabenzoquinone imine and its antidote, N-acetyl-l-cysteine"],"prefix":"10.1038","volume":"15","author":[{"given":"Omar M","family":"El-Abassy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Gamal","family":"Fawzy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebraam B.","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,3]]},"reference":[{"key":"86070_CR1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/00045391-200007020-00009","volume":"7","author":"RC Dart","year":"2000","unstructured":"Dart, R. C., Kuffner, E. K. & Rumack, B. H. Treatment of pain or fever with paracetamol (acetaminophen) in the alcoholic patient: A systematic review. Am. J. Ther. 7, 123\u2013134 (2000).","journal-title":"Am. J. Ther."},{"key":"86070_CR2","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/978-3-642-00663-0_12","volume":"10","author":"JA Hinson","year":"2010","unstructured":"Hinson, J. A., Roberts, D. W. & James, L. P. Mechanisms of acetaminophen-induced liver necrosis. Advers. Drug React. 10, 369\u2013405 (2010).","journal-title":"Advers. Drug React."},{"key":"86070_CR3","volume-title":"Transnational Cinema: The Film Reader","author":"E Ezra","year":"2006","unstructured":"Ezra, E. & Rowden, T. Transnational Cinema: The Film Reader (Taylor & Francis, London, 2006)."},{"key":"86070_CR4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.18049\/jcmad\/232","volume":"2","author":"UB Ghaffar","year":"2014","unstructured":"Ghaffar, U. B. & Tadvi, N. A. Paracetamol toxicity: A review. J. Contemp. Med. A Dent. 2, 12\u201315 (2014).","journal-title":"J. Contemp. Med. A Dent."},{"key":"86070_CR5","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1191\/0960327103ht325oa","volume":"22","author":"AH McGregor","year":"2003","unstructured":"McGregor, A. H., More, L. J., Simpson, K. J. & Harrison, D. J. Liver death and regeneration in paracetamol toxicity. Hum. Exp. Toxicol. 22, 221\u2013227 (2003).","journal-title":"Hum. Exp. Toxicol."},{"key":"86070_CR6","doi-asserted-by":"publisher","first-page":"503","DOI":"10.2165\/00002018-200124070-00003","volume":"24","author":"E Kozer","year":"2001","unstructured":"Kozer, E. & Koren, G. Management of paracetamol overdose: Current controversies. Drug Saf. 24, 503\u2013512 (2001).","journal-title":"Drug Saf."},{"key":"86070_CR7","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.redox.2016.10.001","volume":"10","author":"K Du","year":"2016","unstructured":"Du, K., Ramachandran, A. & Jaeschke, H. Oxidative stress during acetaminophen hepatotoxicity: Sources, pathophysiological role and therapeutic potential. Redox Biol. 10, 148\u2013156 (2016).","journal-title":"Redox Biol."},{"key":"86070_CR8","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1007\/s11095-013-1007-6","volume":"30","author":"MR McGill","year":"2013","unstructured":"McGill, M. R. & Jaeschke, H. Metabolism and disposition of acetaminophen: Recent advances in relation to hepatotoxicity and diagnosis. Pharm. Res. 30, 2174\u20132187 (2013).","journal-title":"Pharm. Res."},{"key":"86070_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-230X-11-20","volume":"11","author":"KJ Heard","year":"2011","unstructured":"Heard, K. J. et al. Acetaminophen-cysteine adducts during therapeutic dosing and following overdose. BMC Gastroenterol. 11, 1\u20139 (2011).","journal-title":"BMC Gastroenterol."},{"key":"86070_CR10","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1039\/c3ay26614a","volume":"5","author":"T Hairin","year":"2013","unstructured":"Hairin, T. et al. Quantitative LC\/MS\/MS analysis of acetaminophen\u2013cysteine adducts (APAP\u2013CYS) and its application in acetaminophen overdose patients. Anal. Methods 5, 1955\u20131964 (2013).","journal-title":"Anal. Methods"},{"key":"86070_CR11","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1021\/tx9700937","volume":"10","author":"TJ Monks","year":"1997","unstructured":"Monks, T. J. & Lau, S. S. Biological reactivity of polyphenolic\u2212glutathione conjugates. Chem. Res. Toxicol. 10, 1296\u20131313 (1997).","journal-title":"Chem. Res. Toxicol."},{"key":"86070_CR12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0378-4274(00)00285-X","volume":"124","author":"W Dekant","year":"2001","unstructured":"Dekant, W. Chemical-induced nephrotoxicity mediated by glutathione S-conjugate formation. Toxicol. Lett. 124, 21\u201336 (2001).","journal-title":"Toxicol. Lett."},{"key":"86070_CR13","doi-asserted-by":"crossref","unstructured":"Rou\u0161ar, T., Parik, P., Kucera, O., Barto\u0161, M. & Cervinkov\u00e1, Z. Glutathione reductase is inhibited by acetaminophen-glutathione conjugate in vitro. Physiol. Res. 59 (2010).","DOI":"10.33549\/physiolres.931744"},{"key":"86070_CR14","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1002\/jat.2914","volume":"34","author":"E N\u00fddlov\u00e1","year":"2014","unstructured":"N\u00fddlov\u00e1, E. et al. Comparison of inhibitory effects between acetaminophen\u2013glutathione conjugate and reduced glutathione in human glutathione reductase. J. Appl. Toxicol. 34, 968\u2013973 (2014).","journal-title":"J. Appl. Toxicol."},{"key":"86070_CR15","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ab.2007.11.011","volume":"374","author":"AK Hewavitharana","year":"2008","unstructured":"Hewavitharana, A. K., Lee, S., Dawson, P. A., Markovich, D. & Shaw, P. N. Development of an HPLC\u2013MS\/MS method for the selective determination of paracetamol metabolites in mouse urine. Anal. Biochem. 374, 106\u2013111 (2008).","journal-title":"Anal. Biochem."},{"key":"86070_CR16","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.4155\/bio.12.119","volume":"4","author":"W Li","year":"2012","unstructured":"Li, W., Doherty, J. P., Kulmatycki, K., Smith, H. T. & Tse, F. L. S. Simultaneous LC\u2013MS\/MS quantitation of acetaminophen and its glucuronide and sulfate metabolites in human dried blood spot samples collected by subjects in a pilot clinical study. Bioanalysis 4, 1429\u20131443 (2012).","journal-title":"Bioanalysis"},{"key":"86070_CR17","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1002\/bmc.2737","volume":"26","author":"JH An","year":"2012","unstructured":"An, J. H., Lee, H. J. & Jung, B. H. Quantitative analysis of acetaminophen and its six metabolites in rat plasma using liquid chromatography\/tandem mass spectrometry. Biomed. Chromatogr. 26, 1596\u20131604 (2012).","journal-title":"Biomed. Chromatogr."},{"key":"86070_CR18","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1093\/jat\/bks139","volume":"37","author":"T Gicquel","year":"2013","unstructured":"Gicquel, T., Aubert, J., Lepage, S., Fromenty, B. & Morel, I. Quantitative analysis of acetaminophen and its primary metabolites in small plasma volumes by liquid chromatography\u2013tandem mass spectrometry. J. Anal. Toxicol. 37, 110\u2013116 (2013).","journal-title":"J. Anal. Toxicol."},{"key":"86070_CR19","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jchromb.2015.10.013","volume":"1007","author":"SF Cook","year":"2015","unstructured":"Cook, S. F., King, A. D., van den Anker, J. N. & Wilkins, D. G. Simultaneous quantification of acetaminophen and five acetaminophen metabolites in human plasma and urine by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry: Method validation and application to a neonatal pharmacokinetic study. Chromatogr. B Anal. Technol. Biomed. Life Sci. 1007, 30\u201342 (2015).","journal-title":"Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"86070_CR20","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.3390\/molecules26072046","volume":"26","author":"K Pietruk","year":"2021","unstructured":"Pietruk, K. et al. Development of a multimatrix UHPLC-MS\/MS method for the determination of paracetamol and its metabolites in animal tissues. Molecules 26, 2046 (2021).","journal-title":"Molecules"},{"key":"86070_CR21","doi-asserted-by":"publisher","first-page":"114361","DOI":"10.1016\/j.jpba.2021.114361","volume":"206","author":"L Delahaye","year":"2021","unstructured":"Delahaye, L., De Baerdemaeker, L. & Stove, C. P. Determination of paracetamol and its metabolites via LC-MS\/MS in dried blood volumetric absorptive microsamples: A tool for pharmacokinetic studies. J. Pharm. Biomed. Anal. 206, 114361 (2021).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"86070_CR22","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/S0731-7085(98)00084-3","volume":"17","author":"A Di Girolamo","year":"1998","unstructured":"Di Girolamo, A., O\u2019Neill, W. M. & Wainer, I. W. A validated method for the determination of paracetamol and its glucuronide and sulphate metabolites in the urine of HIV+\/AIDS patients using wavelength-switching UV detection. J. Pharm. Biomed. Anal. 17, 1191\u20131197 (1998).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"86070_CR23","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S0731-7085(02)00174-7","volume":"29","author":"EJ Oliveira","year":"2002","unstructured":"Oliveira, E. J., Watson, D. G. & Morton, N. S. A simple microanalytical technique for the determination of paracetamol and its main metabolites in blood spots. J. Pharm. Biomed. Anal. 29, 803\u2013809 (2002).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"86070_CR24","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S0731-7085(03)00246-2","volume":"32","author":"MV Vertzoni","year":"2003","unstructured":"Vertzoni, M. V., Archontaki, H. A. & Galanopoulou, P. Development and optimization of a reversed-phase high-performance liquid chromatographic method for the determination of acetaminophen and its major metabolites in rabbit plasma and urine after a toxic dose. J. Pharm. Biomed. Anal. 32, 487\u2013493 (2003).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"86070_CR25","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1002\/bmc.1511","volume":"25","author":"C Flores-P\u00e9rez","year":"2011","unstructured":"Flores-P\u00e9rez, C. et al. A reliable method of liquid chromatography for the quantification of acetaminophen and identification of its toxic metabolite N-acetyl-p-benzoquinoneimine for application in pediatric studies. Biomed. Chromatogr. 25, 760\u2013766 (2011).","journal-title":"Biomed. Chromatogr."},{"key":"86070_CR26","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1002\/ptr.6365","volume":"33","author":"R Pingili","year":"2019","unstructured":"Pingili, R., Pawar, A. K. & Challa, S. R. Quercetin reduced the formation of N-acetyl-p-benzoquinoneimine, a toxic metabolite of paracetamol in rats and isolated rat hepatocytes. Phyther. Res. 33, 1770\u20131783 (2019).","journal-title":"Phyther. Res."},{"key":"86070_CR27","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0378-4347(98)00415-0","volume":"721","author":"S Heitmeier","year":"1999","unstructured":"Heitmeier, S. & Blaschke, G. Direct determination of paracetamol and its metabolites in urine and serum by capillary electrophoresis with ultraviolet and mass spectrometric detection. J. Chromatogr. B Biomed. Sci. Appl. 721, 93\u2013108 (1999).","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"86070_CR28","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.chroma.2006.03.048","volume":"1117","author":"S Ullsten","year":"2006","unstructured":"Ullsten, S., Danielsson, R., B\u00e4ckstr\u00f6m, D., Sj\u00f6berg, P. & Bergquist, J. Urine profiling using capillary electrophoresis-mass spectrometry and multivariate data analysis. J. Chromatogr. A 1117, 87\u201393 (2006).","journal-title":"J. Chromatogr. A"},{"key":"86070_CR29","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.talanta.2019.07.003","volume":"205","author":"M Lecoeur","year":"2019","unstructured":"Lecoeur, M. et al. Determination of acetaminophen and its main metabolites in urine by capillary electrophoresis hyphenated to mass spectrometry. Talanta 205, 108\u2013120 (2019).","journal-title":"Talanta"},{"key":"86070_CR30","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1039\/D0AY02169E","volume":"13","author":"M Gamal","year":"2021","unstructured":"Bahgat, E. A., Hashem, H., Saleh, H., Kamel, E. B. & Eissa, M. S.\u00a0HPLC-DAD technique for the quantification of a recently approved anti-diabetic triple combination along with two toxic official impurities: Toxicity confirmation aided by molecular docking application. BMC Chem. 17, 1\u201310 (2023).","journal-title":"Anal. Methods"},{"key":"86070_CR31","doi-asserted-by":"publisher","first-page":"16301","DOI":"10.1039\/D2RA02395D","volume":"12","author":"MA Abdelgawad","year":"2022","unstructured":"Kamel, E. B. & Fawzy, M. G. Two green evaluated stability-indicating chromatographic methodologies for the analysis of a new ophthalmic solution mixture in the existence of their possible degradation products: Application to rabbit aqueous humor. Microchem. J. 207, 111997 (2024).","journal-title":"RSC Adv."},{"key":"86070_CR32","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1002\/jssc.202100980","volume":"45","author":"EB Kamel","year":"2022","unstructured":"Kamel, E. B. Two green chromatographic methods for the quantification of tamsulosin and solifenacin along with four of their impurities. J. Sep. Sci. 45, 1305\u20131316 (2022).","journal-title":"J. Sep. Sci."},{"key":"86070_CR33","doi-asserted-by":"crossref","unstructured":"Bahgat, E. A., Hashem, H., Saleh, H., Kamel, E. B. & Eissa, M. S. Green micelle and complex inclusion enhanced synchronous spectrofluorimetric quantification of a novel analgesic combination: tramadol and celecoxib in tablets dosage form and spiked human plasma. Luminescence 38, 389\u2013400 (2023).","DOI":"10.1002\/bio.4458"},{"key":"86070_CR34","doi-asserted-by":"publisher","first-page":"109511","DOI":"10.1016\/j.microc.2023.109511","volume":"195","author":"FK Algethami","year":"2023","unstructured":"Algethami, F. K. & Gamal, M. Development of a simple, eco-friendly HPLC-DAD method for tulathromycin analysis: Ensuring stability and assessing greenness. Microchem. J. 195, 109511 (2023).","journal-title":"Microchem. J."},{"key":"86070_CR35","doi-asserted-by":"publisher","first-page":"10076","DOI":"10.1021\/acs.analchem.0c01887","volume":"92","author":"F Pena-Pereira","year":"2020","unstructured":"Pena-Pereira, F., Wojnowski, W. & Tobiszewski, M. AGREE\u2014Analytical GREEnness metric approach and software. Anal. Chem. 92, 10076\u201310082 (2020).","journal-title":"Anal. Chem."},{"key":"86070_CR36","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.talanta.2018.01.013","volume":"181","author":"J P\u0142otka-Wasylka","year":"2018","unstructured":"P\u0142otka-Wasylka, J. A new tool for the evaluation of the analytical procedure: Green analytical procedure index. Talanta 181, 204\u2013209 (2018).","journal-title":"Talanta"},{"key":"86070_CR37","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/9781118971147.ch5","volume":"5","author":"P Borman","year":"2017","unstructured":"Borman, P. & Elder, D. Q2 (R1) validation of analytical procedures. ICH Qual. Guidel. 5, 127\u2013166 (2017).","journal-title":"ICH Qual. Guidel."},{"key":"86070_CR38","doi-asserted-by":"crossref","unstructured":"Variyar, P. S., Chatterjee, S. & Sharma, A. Fundamentals and theory of HPTLC-based separation. In High-Performance Thin-Layer Chromatography (HPTLC) 27\u201339 (Springer, 2011).","DOI":"10.1007\/978-3-642-14025-9_2"},{"key":"86070_CR39","unstructured":"United States Pharmacopeia and The National Formulary (USP 42-NF 37, U.S. Pharmacopeial Convention, Rockville MD, USA, 2019)."},{"key":"86070_CR40","doi-asserted-by":"publisher","first-page":"117211","DOI":"10.1016\/j.trac.2023.117211","volume":"166","author":"M Shi","year":"2023","unstructured":"Shi, M. et al. Overview of sixteen green analytical chemistry metrics for evaluation of the greenness of analytical methods. TrAC Trends Anal. Chem. 166, 117211 (2023).","journal-title":"TrAC Trends Anal. Chem."},{"key":"86070_CR41","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3390\/separations9020049","volume":"9","author":"AE Ibrahim","year":"2022","unstructured":"Bahgat, E. A., Hashem, H., Saleh, H., Kamel, E. B. & Eissa, M. S. Manipulation and Processing of Spectral Signals for the Assay of the Newly Authorized Mixture of Bupivacaine\/Meloxicam Using Fully Green Solvents and a Comparative Green Evaluation Supporting the Greenness and Sustainability of the Developed Smart Spectrophotometric Methods. J. AOAC Inter.\u00a0106, 1056\u2013069 (2023).","journal-title":"Separations"},{"key":"86070_CR42","doi-asserted-by":"publisher","first-page":"122911","DOI":"10.1016\/j.saa.2023.122911","volume":"300","author":"MG Fawzy","year":"2023","unstructured":"Fawzy, M. G. & Kamel, E. B. Sustainable stability-indicating spectra manipulations for the concurrent quantification of a novel anti-COVID-19 drug and its active metabolite: Green profile assessment. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 300, 122911 (2023).","journal-title":"Spectrochim. Acta Part A Mol. Biomol. Spectrosc."},{"key":"86070_CR43","doi-asserted-by":"publisher","first-page":"7598","DOI":"10.1039\/D3GC02347H","volume":"25","author":"N Manousi","year":"2023","unstructured":"Manousi, N., Wojnowski, W., P\u0142otka-Wasylka, J. & Samanidou, V. Blue applicability grade index (BAGI) and software: A new tool for the evaluation of method practicality. Green Chem. 25, 7598\u20137604 (2023).","journal-title":"Green Chem."},{"key":"86070_CR44","doi-asserted-by":"publisher","first-page":"101294","DOI":"10.1016\/j.scp.2023.101294","volume":"36","author":"MA El Hamd","year":"2023","unstructured":"El Hamd, M. A. et al. Roth\u2019s switch-on fluoremetric probe for green tracking and quantifying of 1.4-dihydropyridine medication: Evaluation of greenness, whiteness, and blueness. Sustain. Chem. Pharm. 36, 101294 (2023).","journal-title":"Sustain. Chem. Pharm."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86070-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86070-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86070-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T04:42:18Z","timestamp":1738644138000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86070-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,3]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["86070"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-86070-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,3]]},"assertion":[{"value":"24 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4119"}}